Physician profile
Mary J Eoff
NPI 1316997547
$1,702.37
in general payments reported to CMS, 2019-2025
11 companies · $739 in 2025
The $739 reported for 2025 was more than what 97% of Pediatrics (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $90.40).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.03 · 2022: $555 · 2024: $318 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $451.41 | 2021-2024 | Spravato |
| Amgen INC. | $218.95 | 2025 | Krystexxa, Repatha |
| Abiomed | $138.96 | 2025 | |
| Boston Scientific Corporation | $134.58 | 2025 | Watchman Flx |
| Axsome Therapeutics, INC. | $124.94 | 2025 | Auvelity |
| Sanofi-Aventis U.S. LLC | $121.36 | 2025 | |
| Sk Life Science, INC. | $121.09 | 2022 | |
| Neurocrine Biosciences, INC. | $104.37 | 2024 | Ingrezza |
| Abbvie INC. | $99.33 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $96.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Eoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.